Refractory Anemia
specificA myelodysplastic syndrome characterized mainly by dysplasia of the erythroid series. Refractory anemia is uncommon. It is primarily a disease of older adults. The median survival exceeds 5 years. (WHO, 2001)
13
Centers
2
Active Trials
$1M
Cancer Funding
Top Centers for Refractory Anemia(13)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive High-Volume Research Center | 71.5 |
| 2 | University of Illinois Cancer CenterChicago, IL High-Volume Research Center | 71.5 |
| 3 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 66.5 |
| 4 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 49.0 |
| 5 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 49.0 |
| 6 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 49.0 |
| 7 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive | 49.0 |
| 8 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 49.0 |
| 9 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive | 49.0 |
| 10 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 49.0 |
| 11 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 49.0 |
| 12 | Medical College of Wisconsin Cancer CenterMilwaukee, WI | 49.0 |
| 13 | Cleveland Clinic Cancer CenterCleveland, OH | 49.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →